SCHEMBL27323499

SCHEMBL27323499

Fc1cccc(Nc2cc(NC3CC3)ncn2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
MAPK1 P28482 2/20 0.51
HTT P42858 2/20 0.51
KDM4E B2RXH2 2/20 0.51
LMNA P02545 1/20 0.51
MAPK10 P53779 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MKNK1 Q9BUB5 1/20 0.45
EGFR P00533 5/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
ERBB4 Q15303 1/20 0.44
ABL1 P00519 2/20 0.43
BCR P11274 2/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
CTSK P43235 1/20 0.43
RAB9A P51151 3/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27338346 0.85 MEN1 (0.44) MEN1KMT2AEGFRCTSLCTSB
SCHEMBL27317919 0.84 EGFR (0.49) MEN1KMT2AMAPK1LMNAMAPK10
SCHEMBL27330845 0.83 TNNI3K (0.54) EGFRABCG2TNNI3K
SCHEMBL27339277 0.83 EGFR (0.45) MEN1KMT2AEGFRERBB4RAB9A
SCHEMBL27339286 0.82 PRCP (0.49) MEN1KMT2AEGFRERBB4RAB9A
SCHEMBL27338340 0.81 KCNQ3 (0.48) MEN1KMT2AMAPK1HTTSMN1; SMN2
SCHEMBL27334593 0.80 EGFR (0.41) MEN1KMT2AEGFRERBB4RAB9A
SCHEMBL27318731 0.80 EGFR (0.47) MEN1KMT2AHTTKDM4ELMNA
SCHEMBL27345375 0.80 MEN1 (0.69) MEN1KMT2AMAPK1LMNAEGFR
SCHEMBL27320738 0.80 KDM1A (0.48) EGFRABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1047778-C Pyrimido [5-4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them THOMAE GMBH DR K (DE) 1999-12-29 CN disclosed